Literature DB >> 23849412

Benefits of standardizing the treatment of arrhythmias in the sheep (Ovis aries) model of chronic heart failure after myocardial infarction.

Adrienne Dardenne1, Carlos Fernandez, Alyssa Wagner, Krzysztof Milewski, Diane R Ordanes, Patricia A Mount, Yanping Cheng, Geng-Hua Yi, Gerard B Conditt, Armando Tellez, Greg L Kaluza, Juan F Granada, William P Feeney.   

Abstract

Large animal models of heart failure are essential in preclinical device testing. In sheep, catheter-based coil embolization of the left anterior descending and diagonal artery provides a minimally invasive and reproducible model of myocardial infarction (MI). Although widely used, this model has historically been plagued with a 30% mortality rate, both in the literature and in our own experience. Our study endeavored to decrease the mortality rate by targeting the most common cause of death, intractable arrhythmias, during creation of the ovine MI model. To this end, we evaluated 2 methods of managing perioperative antiarrhythmic therapy and cardiopulmonary resuscitation during model creation. The first group of sheep was managed at the discretion of the individual operator, whereas the second group was treated according to a standardized protocol that included mandatory pretreatment with amiodarone. Sheep experiencing life-threatening arrhythmias, most commonly ventricular fibrillation, were either resuscitated according to operator-driven instructions or the standardized protocol. By comparing these 2 treatment groups, we have shown that using a standardized protocol is advantageous in reducing mortality associated with the ovine MI model. Since implementing the standardized protocol, our laboratory has lowered the expected mortality rate to 10% during catheter-based induction of ovine MI and has greatly reduced the number of animals required for study needs. In addition, the standardized protocol has proven beneficial in training new staff members. By implementing this standardized method of model management, the outcomes of model creation have been optimized.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23849412      PMCID: PMC3690451     

Source DB:  PubMed          Journal:  J Am Assoc Lab Anim Sci        ISSN: 1559-6109            Impact factor:   1.232


  20 in total

1.  Part 2: International collaboration in resuscitation science: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations.

Authors:  Vinay M Nadkarni; Jerry P Nolan; John E Billi; Leo Bossaert; Bernd W Böttiger; Douglas Chamberlain; Saul Drajer; Brian Eigel; Mary Fran Hazinski; Robert W Hickey; Ian Jacobs; Walter Kloeck; William H Montgomery; Peter T Morley; Robert E O'Connor; Kazuo Okada; Michael Shuster; Andrew H Travers; David Zideman
Journal:  Circulation       Date:  2010-10-19       Impact factor: 29.690

2.  Comparison of the efficacy of nifekalant and amiodarone in a porcine model of cardiac arrest.

Authors:  Xian-Fei Ji; Chun-Sheng Li; Shuo Wang; Lin Yang; Lu-Hong Cong
Journal:  Resuscitation       Date:  2010-06-02       Impact factor: 5.262

3.  Part 7: CPR techniques and devices: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations.

Authors:  Michael Shuster; Swee Han Lim; Charles D Deakin; Monica E Kleinman; Rudolph W Koster; Laurie J Morrison; Jerry P Nolan; Michael R Sayre
Journal:  Circulation       Date:  2010-10-19       Impact factor: 29.690

4.  An ovine model of chronic heart failure: echocardiographic and tissue Doppler imaging characterization.

Authors:  Nicolas Borenstein; Patrick Bruneval; Luc Behr; François Laborde; Didier Montarras; Jean Pierre Daurès; Geneviève Derumeaux; Jean-Louis Pouchelon; Valérie Chetboul
Journal:  J Card Surg       Date:  2006 Jan-Feb       Impact factor: 1.620

5.  Myocardial infarction with and without reperfusion in sheep: early cardiac and neurohumoral changes.

Authors:  C J Charles; J M Elliott; M G Nicholls; M T Rademaker; M Richards
Journal:  Clin Sci (Lond)       Date:  2000-06       Impact factor: 6.124

6.  Variability of cardiomyocyte DNA content, ploidy level and nuclear number in mammalian hearts.

Authors:  C P Adler; H Friedburg; G W Herget; M Neuburger; H Schwalb
Journal:  Virchows Arch       Date:  1996-10       Impact factor: 4.064

7.  Histological remodeling in an ovine heart failure model resembles human ischemic cardiomyopathy.

Authors:  Y Ikeda; C Yutani; Y Huang; K Masuda; T Yuasa; O Kawaguchi; S N Hunyor
Journal:  Cardiovasc Pathol       Date:  2001 Jan-Feb       Impact factor: 2.185

8.  An ovine model of postinfarction dilated cardiomyopathy.

Authors:  Sina L Moainie; Joseph H Gorman; T Sloane Guy; Frank W Bowen; Benjamin M Jackson; Theodore Plappert; Navneet Narula; Martin G St John-Sutton; Jagat Narula; L Henry Edmunds; Robert C Gorman
Journal:  Ann Thorac Surg       Date:  2002-09       Impact factor: 4.330

9.  Neither vasopressin nor amiodarone improve CPR outcome in an animal model of hypothermic cardiac arrest.

Authors:  B Schwarz; P Mair; H Wagner-Berger; K H Stadlbauer; S Girg; V Wenzel; K H Lindner
Journal:  Acta Anaesthesiol Scand       Date:  2003-10       Impact factor: 2.105

Review 10.  Large animal models of heart failure: a critical link in the translation of basic science to clinical practice.

Authors:  Jennifer A Dixon; Francis G Spinale
Journal:  Circ Heart Fail       Date:  2009-05       Impact factor: 8.790

View more
  6 in total

1.  Strategies to Improve Survival from Surgery for Heart Valve Implantation in Sheep.

Authors:  Annemijn Vis; Jan Cam Lammers; Roel de Vroege; Martijn Mj van Nieuwburg; Marlijn S Jansen; Joyce Mj Visser; Bart Meuris; Paul F Gründeman; Jolanda Kluin
Journal:  Comp Med       Date:  2021-06-03       Impact factor: 0.982

2.  A preclinical large-animal model for the assessment of critical-size load-bearing bone defect reconstruction.

Authors:  David S Sparks; Siamak Saifzadeh; Flavia Medeiros Savi; Constantin E Dlaska; Arne Berner; Jan Henkel; Johannes C Reichert; Martin Wullschleger; Jiongyu Ren; Amaia Cipitria; Jacqui A McGovern; Roland Steck; Michael Wagels; Maria Ann Woodruff; Michael A Schuetz; Dietmar W Hutmacher
Journal:  Nat Protoc       Date:  2020-02-14       Impact factor: 13.491

Review 3.  Aberrant regulation of autophagy in mammalian diseases.

Authors:  Wei Xie; Jun Zhou
Journal:  Biol Lett       Date:  2018-01       Impact factor: 3.703

4.  Trelagliptin ameliorates oxygen-glucose deprivation/reperfusion (OGD/R)-induced mitochondrial dysfunction and metabolic disturbance of endothelial cells.

Authors:  Yatong Zhang; Chao Li; Yifang Pei; Li Zheng; Xuelin Sun; Zinan Zhao; Shuanghu Wang
Journal:  Hum Cell       Date:  2021-08-25       Impact factor: 4.174

5.  Development of nonfibrotic left ventricular hypertrophy in an ANG II-induced chronic ovine hypertension model.

Authors:  Niklas Klatt; Katharina Scherschel; Claudia Schad; Denise Lau; Aline Reitmeier; Pawel Kuklik; Kai Muellerleile; Jin Yamamura; Tanja Zeller; Daniel Steven; Stephan Baldus; Benjamin Schäffer; Christiane Jungen; Christian Eickholt; Katharina Wassilew; Edzard Schwedhelm; Stephan Willems; Christian Meyer
Journal:  Physiol Rep       Date:  2016-09

6.  A clinically relevant sheep model of orthotopic heart transplantation 24 h after donor brainstem death.

Authors:  Louise E See Hoe; Karin Wildi; Nchafatso G Obonyo; Nicole Bartnikowski; Charles McDonald; Kei Sato; Silver Heinsar; Sanne Engkilde-Pedersen; Sara Diab; Margaret R Passmore; Matthew A Wells; Ai-Ching Boon; Arlanna Esguerra; David G Platts; Lynnette James; Mahe Bouquet; Kieran Hyslop; Tristan Shuker; Carmen Ainola; Sebastiano M Colombo; Emily S Wilson; Jonathan E Millar; Maximillian V Malfertheiner; Janice D Reid; Hollier O'Neill; Samantha Livingstone; Gabriella Abbate; Noriko Sato; Ting He; Viktor von Bahr; Sacha Rozencwajg; Liam Byrne; Leticia P Pimenta; Lachlan Marshall; Lawrie Nair; John-Paul Tung; Jonathan Chan; Haris Haqqani; Peter Molenaar; Gianluigi Li Bassi; Jacky Y Suen; David C McGiffin; John F Fraser
Journal:  Intensive Care Med Exp       Date:  2021-12-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.